<VariationArchive VariationID="422936" VariationName="NM_000092.5(COL4A4):c.2628_2654dup (p.Arg877_Gly885dup)" VariationType="Duplication" Accession="VCV000422936" Version="9" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-23" DateCreated="2017-04-29" MostRecentSubmission="2023-02-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="405642" VariationID="422936">
      <GeneList>
        <Gene Symbol="COL4A4" FullName="collagen type IV alpha 4 chain" GeneID="1286" HGNC_ID="HGNC:2206" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="226967360" stop="227164488" display_start="226967360" display_stop="227164488" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227867426" stop="228029274" display_start="227867426" display_stop="228029274" Strand="-" />
          </Location>
          <OMIM>120131</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000092.5(COL4A4):c.2628_2654dup (p.Arg877_Gly885dup)</Name>
      <CanonicalSPDI>NC_000002.12:227056006:CCTGGGGGACCATGTGCCCCAGGCCGTCCTGGG:CCTGGGGGACCATGTGCCCCAGGCCGTCCTGGGGGACCATGTGCCCCAGGCCGTCCTGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q36.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227056006" stop="227056007" display_start="227056006" display_stop="227056007" variantLength="27" positionVCF="227056006" referenceAlleleVCF="G" alternateAlleleVCF="GCCTGGGGGACCATGTGCCCCAGGCCGT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227920722" stop="227920723" display_start="227920722" display_stop="227920723" variantLength="27" positionVCF="227920722" referenceAlleleVCF="G" alternateAlleleVCF="GCCTGGGGGACCATGTGCCCCAGGCCGT" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_231" sequenceAccession="LRG_231">
            <Expression>LRG_231:g.113527_113553dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000092.4" sequenceAccession="NM_000092" sequenceVersion="4" change="c.2628_2654dupACGGCCTGGGGCACATGGTCCCCCAGG">
            <Expression>NM_000092.4:c.2628_2654dupACGGCCTGGGGCACATGGTCCCCCAGG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.227920729_227920755dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.227920729_227920755dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227056013_227056039dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.227056013_227056039dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011592.1" sequenceAccession="NG_011592" sequenceVersion="1" change="g.113527_113553dup">
            <Expression>NG_011592.1:g.113527_113553dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000092.5" sequenceAccession="NM_000092" sequenceVersion="5" change="c.2628_2654dup" MANESelect="true">
            <Expression>NM_000092.5:c.2628_2654dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000083.3" sequenceAccession="NP_000083" sequenceVersion="3" change="p.Arg877_Gly885dup">
            <Expression>NP_000083.3:p.Arg877_Gly885dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16617486" DB="ClinGen" />
        <XRef Type="rs" ID="1553641597" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="Unknown function" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000092.5(COL4A4):c.2628_2654dup (p.Arg877_Gly885dup) AND not provided" Accession="RCV000480791" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-08-31" SubmissionCount="2">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000092.5(COL4A4):c.2628_2654dup (p.Arg877_Gly885dup) AND Autosomal recessive Alport syndrome" Accession="RCV000495560" Version="2">
        <ClassifiedConditionList TraitSetID="5721">
          <ClassifiedCondition DB="MedGen" ID="C4746745">Autosomal recessive Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000092.5(COL4A4):c.2628_2654dup (p.Arg877_Gly885dup) AND Autosomal dominant Alport syndrome" Accession="RCV002244953" Version="3">
        <ClassifiedConditionList TraitSetID="5740">
          <ClassifiedCondition DB="MedGen" ID="C5882663">Autosomal dominant Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-19" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2017-04-29" MostRecentSubmission="2023-02-07">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(2)</Explanation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(2)</Comment>
        <DescriptionHistory Dated="2022-05-21">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5721" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="282" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                <XRef ID="MONDO:0008762" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS2</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="625" />
                <XRef ID="625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88919" DB="Orphanet" />
              <XRef ID="C4746745" DB="MedGen" />
              <XRef ID="MONDO:0008762" DB="MONDO" />
              <XRef Type="MIM" ID="203780" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5740" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="158" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome 3, autosomal dominant</ElementValue>
                <XRef ID="Alport+Syndrome+Dominant+Type/336" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant Alport syndrome</ElementValue>
                <XRef ID="MONDO:0007086" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport syndrome dominant type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal failure and sensorineural hearing loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS3A</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="624" />
                <XRef ID="624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88918" DB="Orphanet" />
              <XRef ID="C5882663" DB="MedGen" />
              <XRef ID="MONDO:0007086" DB="MONDO" />
              <XRef Type="MIM" ID="104200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1137278" SubmissionDate="2017-07-14" DateLastUpdated="2017-07-17" DateCreated="2017-07-17">
        <ClinVarSubmissionID localKey="SUB2866307" submittedAssembly="hg19" title="SUB2866307" />
        <ClinVarAccession Accession="SCV000583562" DateUpdated="2017-07-17" DateCreated="2017-07-17" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, Cologne University" OrgID="243629" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A4">
              <Name>collagen type IV alpha 4 chain</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000092.4:c.2628_2654dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203780" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2866307</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1107642" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-29" DateCreated="2017-04-29">
        <ClinVarSubmissionID localKey="GDX:1425111|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000572535" DateUpdated="2017-04-29" DateCreated="2017-04-29" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The c.2628_2654dup27 variant in the COL4A4 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.2628_2654dup27 variant causes an in-frame duplication of nine amino acid residues within the triple helical region of the COL4A4 protein, beginning with Arginine 877 and ending with Glycine 885, denoted p.Arg877_Gly885dup. The c.2628_2654dup27 variant was not observed in approximately 5,900 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.2628_2654dup27 as a variant of uncertain significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="CCTGGGGGACCATGTGCCCCAGGCCGTCCTGGGGGACCATGTGCCCCAGGCCGT" referenceAllele="CCTGGGGGACCATGTGCCCCAGGCCGT" start="227920722" stop="227920723" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000092.4:c.2628_2654dup27</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4927597" SubmissionDate="2022-05-19" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="SUB11497788" submittedAssembly="hg19" title="SUB11497788" />
        <ClinVarAccession Accession="SCV002515802" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Centro de Bioquimica y Genetica Clinica, Servicio Murciano de Salud" OrgID="508468" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.(Arg877_Glu885dup) variant does not produce a frameshift; however, it results in a 9 amino acid increase in the length of the Î±4 chain of type IV collagen, in a non-repetitive "triple helix" region of the protein. This variant has been identified in heterozygous state in 7 families from our internal database of patients with symptoms of Alport syndrome or familial microhematuria, and was absent in the rest of our patients without kidney disease. Segregation studies in three of the affected families showed that this duplication co-segregated with the presence of kidney disease. The c.2628_2654dup variant meets the ACMG criteria: PM1, PM2, PM4, PP1 and PS4, and is classified as Pathogenic</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Ethnicity>European (Non-Finnish)</Ethnicity>
              <GeographicOrigin>Spain</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">28</Age>
              <Age Type="maximum" age_unit="years">67</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>mixed</Gender>
              <FamilyData NumFamiliesWithVariant="7" />
            </Sample>
            <Method>
              <NamePlatform>MiSeq</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="14" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="14" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002907" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000093" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000365" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A4">
              <Name>collagen type IV alpha 4 chain</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000092.5:exon 30</GeneLocation>
          </Location>
          <FunctionalConsequence Value="Unknown function" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_000092.5:c.2628_2654dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="104200" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11497788</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2922819" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2021-03-07">
        <ClinVarSubmissionID localKey="8841326|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001483189" DateUpdated="2023-02-07" DateCreated="2021-03-07" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>This variant, c.2628_2654dup, results in the insertion of 9 amino acid(s) to the COL4A4 protein (p.Arg877_Gly885dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with COL4A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 422936). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.227920722_227920723insCCTGGGGGACCATGTGCCCCAGGCCGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4927597" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000093" MappingRef="HP">
        <MedGen CUI="C0033687" Name="Proteinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1137278" TraitType="Disease" MappingType="XRef" MappingValue="203780" MappingRef="OMIM">
        <MedGen CUI="C4746745" Name="Autosomal recessive Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4927597" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000365" MappingRef="HP">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4927597" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002907" MappingRef="HP">
        <MedGen CUI="C0239937" Name="Microscopic hematuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4927597" TraitType="Disease" MappingType="XRef" MappingValue="104200" MappingRef="OMIM">
        <MedGen CUI="C5882663" Name="Autosomal dominant Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1107642" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2922819" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

